Beneficial effect of endo-CRT might be mediated by more improvement of SERCA2A in chronic dyssynchronous canine heart failure models

Hongyun Chen; Hongyun Chen; Shuang Liu; Shuang Liu; Zhihong Zong; Zhihong Zong; Cuiting Zhao; Cuiting Zhao; Guangyuan Li; Guangyuan Li; Yonghuai Wang; Yonghuai Wang; Guoxian Qi; Guoxian Qi; Jun Yang; Jun Yang; Chunyan Ma; Chunyan Ma

doi:10.18632/oncotarget.24060

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/06/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Beneficial effect of endo-CRT might be mediated by more improvement of SERCA2A in chronic dyssynchronous canine heart failure models

Hongyun Chen _, Hongyun Chen, Shuang Liu, Shuang Liu, Zhihong Zong, Zhihong Zong, Cuiting Zhao, Cuiting Zhao, Guangyuan Li, Guangyuan Li, Yonghuai Wang, Yonghuai Wang, Guoxian Qi, Guoxian Qi, Jun Yang, Jun Yang, Chunyan Ma and Chunyan Ma _

Hongyun Chen1, Shuang Liu2, Zhihong Zong3, Cuiting Zhao2, Guangyuan Li2, Yonghuai Wang2, Guoxian Qi1, Jun Yang2 and Chunyan Ma2

1 Department of Geriatric Cardiology, First Hospital of China Medical University, Shenyang, Liaoning, China

2 Department of Cardiovascular Ultrasound, First Hospital of China Medical University, Shenyang, Liaoning, China

3 China Medical University, Shenyang, Liaoning, China

Correspondence to:

Chunyan Ma, email: [email protected]

Keywords: cardiac resynchronization therapy (CRT); SERCA2A; endo-CRT; epi-CRT; dyssynchronous heart failure

Received: March 29, 2017 Accepted: December 29, 2017 Epub: January 06, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24060

Publication Alerts

Withdrawal Notice

Research Papers:

Beneficial effect of endo-CRT might be mediated by more improvement of SERCA2A in chronic dyssynchronous canine heart failure models